Guilty is Guilty, but Theranos still raises a host of questions for investors – how to trade risk, opportunity and due diligence, and who and what can you trust?
Guilty is Guilty, but Theranos still raises a host of questions for investors – how to trade risk, opportunity and due diligence, and who and what can you trust?